Literature DB >> 10076994

Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras.

C S Lim1, C T Baumann, H Htun, W Xian, M Irie, C L Smith, G L Hager.   

Abstract

Subcellular localization and transcriptional activity of green fluorescent protein-progesterone receptor A and B chimeras (GFP-PRA and GFP-PRB) were examined in living mammalian cells. Both GFP-PRA and B chimeras were found to be similar in transcriptional activity compared with their non-GFP counterparts. GFP-PRA and PRA were both weakly active, while GFP-PRB and PRB gave a 20- to 40-fold induction using a reporter gene containing the full-length mouse mammary tumor virus long-terminal repeat linked to the luciferase gene (pLTRluc). Using fluorescence microscopy, nuclear/cytoplasmic distributions for the unliganded and hormone activated forms of GFP-PRA and GFP-PRB were characterized. The two forms of the receptor were found to have distinct intracellular distributions; GFP-PRA was found to be more nuclear than GFP-PRB in four cell lines examined. The causes for and implications of this differential localization of the A and B forms of the human PR are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076994     DOI: 10.1210/mend.13.3.0247

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  32 in total

1.  Correlation among agonist dose, rate of import, and transcriptional activity of liganded progesterone receptor B isoform in living cells.

Authors:  Henan Li; Guang Yan; Steven E Kern; Carol S Lim
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

2.  The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain.

Authors:  Andrew S Dixon; Carol S Lim
Journal:  Biotechniques       Date:  2010-07       Impact factor: 1.993

3.  FRAP analysis of nucleocytoplasmic dynamics of the vitamin D receptor splice variant VDRB1: preferential targeting to nuclear speckles.

Authors:  Kathryn L Sunn; John A Eisman; Edith M Gardiner; David A Jans
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domain.

Authors:  Mudit Kakar; James R Davis; Steve E Kern; Carol S Lim
Journal:  J Control Release       Date:  2007-05-03       Impact factor: 9.776

5.  Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switch.

Authors:  Mudit Kakar; Amy B Cadwallader; James R Davis; Carol S Lim
Journal:  Pharm Res       Date:  2007-06-13       Impact factor: 4.200

6.  FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform.

Authors:  Zuocheng Yang; Irene M Wolf; Hanying Chen; Sumudra Periyasamy; Zhuang Chen; Weidong Yong; Shu Shi; Weihong Zhao; Jianming Xu; Arun Srivastava; Edwin R Sánchez; Weinian Shou
Journal:  Mol Endocrinol       Date:  2006-07-27

7.  Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.

Authors:  Ramesh Narayanan; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

8.  Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.

Authors:  Geetha V Rayasam; Cem Elbi; Dawn A Walker; Ronald Wolford; Terace M Fletcher; Dean P Edwards; Gordon L Hager
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.

Authors:  Caroline H Diep; Todd P Knutson; Carol A Lange
Journal:  Mol Cancer Res       Date:  2015-11-17       Impact factor: 5.852

10.  Phosphorylation state of tyrosine hydroxylase in the stalk-median eminence is decreased by progesterone in cycling female rats.

Authors:  Bin Liu; Lydia A Arbogast
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.